$14.29
3.28%
NYSE, Feb 28, 09:17 pm CET
ISIN
US58470H1014
Symbol
MED

Medifast Inc Target price 2025 - Analyst rating & recommendation

Medifast Inc Classifications & Recommendation:

Hold
100%

Medifast Inc Price Target

Target Price $15.75
Price $13.98
Potential
Number of Estimates 2
2 Analysts have issued a price target Medifast Inc 2026 . The average Medifast Inc target price is $15.75. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 2 analysts: 0 Analysts recommend Medifast Inc to buy, 2 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Medifast Inc stock has an average upside potential 2026 of . Most analysts recommend the Medifast Inc stock at Hold.

Sales and Margin forecast 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 602.46 442.35
43.80% 26.58%
EBITDA Margin 3.37% 1.58%
74.96% 53.06%
Net Margin 0.35% -1.06%
96.28% 407.23%

2 Analysts have issued a sales forecast Medifast Inc 2025 . The average Medifast Inc sales estimate is

$442m
Unlock
. This is
26.58% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$479m 20.56%
Unlock
, the lowest is
$406m 32.59%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $602m 43.80%
2025
$442m 26.58%
Unlock
2026
$452m 2.10%
Unlock

2 Analysts have issued an Medifast Inc EBITDA forecast 2025. The average Medifast Inc EBITDA estimate is

$7.0m
Unlock
. This is
67.27% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$19.6m 8.37%
Unlock
, the lowest is
$-5.6m 126.18%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $20.3m 85.93%
2025
$7.0m 65.48%
Unlock
2026
$6.9m 2.14%
Unlock

EBITDA Margin

2024 3.37% 74.96%
2025
1.58% 53.06%
Unlock
2026
1.52% 3.80%
Unlock

2 Medifast Inc Analysts have issued a net profit forecast 2025. The average Medifast Inc net profit estimate is

$-4.7m
Unlock
. This is
326.11% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$2.1m 0.07%
Unlock
, the lowest is
$-11.5m 652.78%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $2.1m 97.91%
2025
$-4.7m 326.11%
Unlock
2026
$-5.4m 15.32%
Unlock

Net Margin

2024 0.35% 96.28%
2025
-1.06% 407.23%
Unlock
2026
-1.20% 13.21%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ 0.19 -0.43
97.91% 326.32%
P/E negative
EV/Sales 0.02

2 Analysts have issued a Medifast Inc forecast for earnings per share. The average Medifast Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-0.43
Unlock
. This is
326.32% lower
Unlock
than earnings per share in the financial year 2024. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$0.19 0.00%
Unlock
, the lowest is
$-1.05 652.63%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $0.19 97.91%
2025
$-0.43 326.32%
Unlock
2026
$-0.50 16.28%
Unlock

P/E ratio

Current 73.89 1,553.02%
2025
-32.51 144.00%
Unlock
2026
-28.24 13.13%
Unlock

Based on analysts' sales estimates for 2025, the Medifast Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.01 96.55%
2025
0.02 51.00%
Unlock
2026
0.01 1.99%
Unlock

P/S ratio

Current 0.25 38.70%
2025
0.35 36.21%
Unlock
2026
0.34 2.05%
Unlock

Current Medifast Inc Upgrades & Downgrades Beta

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
DA Davidson Locked ➜ Locked Locked Feb 19 2025
DA Davidson Locked ➜ Locked Locked Nov 05 2024
Analyst Rating Date
Locked
DA Davidson: Locked ➜ Locked
Feb 19 2025
Locked
DA Davidson: Locked ➜ Locked
Nov 05 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today